胰腺腺癌中新发糖尿病与分子亚型无关
Hannah E Trembath1,2, Michelle E LaBella1,2, Joseph F Kearney1
1Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Journal of surgical oncology
|December 23, 2024
概括
新发型糖尿病 (NOD) 并没有预测胰腺管腺癌 (PDAC) 的分子亚型或存活率. 转录基因分析显示,NOD患者的炎症和免疫路径上调.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 基因组学就是基因组学.
背景情况:
- 新发型糖尿病 (NOD) 越来越多地被认为是胰腺管腺癌 (PDAC) 的潜在早期迹象,通常在诊断前长达两年.
- 存在两种经过验证的PDAC分子亚型,提供关于化疗反应的预后和预测价值.
研究的目的:
- 调查新发型糖尿病患者与没有糖尿病或长期糖尿病患者相比,是否表现出不同的分子亚型和预后.
- 探索NOD和PDAC分子特征之间的潜在关联.
主要方法:
- 一个单一机构的研究分析了从2009年到2022年切除的PDAC样本.
- 人口,临床因素和转录基因数据使用双变量和多变量分析进行了检查.
- 患者被分为没有DM史,长期DM (>2年) 和NOD组.
主要成果:
- 在97名患者中,16名患者有NOD. 人口统计数据在各组中都是相似的.
- 在控制共变量后,NOD不是PDAC亚型的显著预测因素.
- 两组之间没有观察到显著的生存差异.
- 转录组分析表明NOD组中的炎症和免疫激活/调节通路的上调.
结论:
- 这项研究是首次探索NOD和PDAC分子亚型和结果之间的关联.
- 研究结果表明,虽然NOD可能不会改变PDAC分子亚型或生存,但潜在的炎症和免疫机制需要进一步调查.
- 需要进行额外的研究,以阐明PDAC的背景下NOD组的病理生理学.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
503
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503


